AHK Romania: Innovative pharmaceutical industry contributes around 5% to Romania's GDP

The innovative pharmaceutical sector in Romania accounts for about 5% of GDP and supports 57,000 jobs. Investments in healthcare are seen as crucial for economic growth and social development. AHK Romania emphasizes the need for innovation and preventive measures in healthcare to reduce future costs. The industry faces challenges, including the lack of access to many innovative medicines. Stakeholders advocate for viewing health as a long-term investment rather than a cost, highlighting the importance of collaboration among various sectors to enhance healthcare infrastructure and services.